Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRV027 dose-ranging study in hospitalized acute decompensated heart failure
2013-002893-35Phase 2Completed
- Sponsor
- Trevena, Inc.
- Start
- Sep 2013
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in heart failure (HF) comparing TRV027 + standard of care with Placebo + standard of care (2 arms). Primary endpoint: Composite clinical endpoint. Started Sep 2013; status: completed.
02
Drugs
TRV120027
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on 2013-002893-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002893-35.